At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
Diagnostic Test: Myostrainprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of MyoStrain™ in Clinical Practice
In Brief
An observational study evaluating Diagnostic Test: Myostrain for Cardiac Failure and 6 related conditions. Completed, enrolled 19 participants across 1 site.
Detailed Summary
Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Failure, Coronary Artery Disease, Sarcoidosis, Amyloidosis, Lupus, Myocarditis, Drug Toxicity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 2019
Enrollment StartApr 2019
Primary CompletionNov 2019
TodayJul 2026
First PostedJan 31, 2019
Enrollment StartApr 15, 2019
Primary CompletionNov 15, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.4 years ago
Interventions
Diagnostic Test: Myostrainprocedure
This test measures the contraction of the heart muscle in one to three heartbeats per plane. It's a pulse sequence that produces images that reveal the underlying contraction fo the muscle of a healthy heart and associated weaknesses in case of disease.